Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Hudson R. Smith
Observed names:
Hudson R Smith,
Hudson Ryan Smith
Institution:
The University of Texas Medical Branch at Galveston
Observed institutions:
Harvard University,
The University of Texas at San Antonio Health Science Center,
The University of Texas Medical Branch at Galveston
ORCID:
0000-0002-0347-0855
Observed ORCID:
0000-0002-0347-0855
OpenAlex ID:
A5039008777
Pharmacological augmentation of nicotinamide phosphoribosyltransferase (NAMPT) protects against paclitaxel-induced peripheral neuropathy
2017
·
Peter M LoCoco
, April L Risinger
, et al.
·
eLife
·
53
PDF
Long‐term antagonism and allosteric regulation of mu opioid receptors by the novel ligand, methocinnamox
2021
·
Joshua C. Zamora
, Hudson R. Smith
, et al.
·
Pharmacology Research & Perspectives
·
17
PDF
Age-related changes in peripheral nociceptor function
2022
·
Elaine M. Jennings
, Laura C. Sullivan
, et al.
·
Neuropharmacology
·
14
PDF
Constitutive activity among orphan G protein-coupled receptors: Molecular mechanisms and pharmacological perspectives
2025
·
Ryan E. Murphy
, Hudson R. Smith
, et al.
·
Molecular Pharmacology
·
8
PDF
Discovery of 3-((4-Benzylpyridin-2-yl)amino)benzamides as Potent GPR52 G Protein-Biased Agonists
2024
·
Ryan E. Murphy
, Pingyuan Wang
, et al.
·
Journal of Medicinal Chemistry
·
8
PDF
Bis-Quinolinium Cyclophane Blockers of SK Potassium Channels Are Antagonists of M3 Muscarinic Acetylcholine Receptors
2020
·
Vladislav Bugay
, Derek J. Wallace
, et al.
·
Frontiers in Pharmacology
·
7
PDF
14-3-3γ mediates the long-term inhibition of peripheral kappa opioid receptor antinociceptive signaling by norbinaltorphimine
2022
·
Michael J. Wedemeyer
, Elaine M. Jennings
, et al.
·
Neuropharmacology
·
5
PDF
Ligand‐Dependent Reversal Kinetics of Mu Opioid Receptor Agonists by the Novel Antagonist, Methocinnamox
2022
·
Hudson R. Smith
, Teresa S. Chavera
, et al.
·
The FASEB Journal
·
1
Agonist‐Dependent Modulation by the Long‐Acting Mu Opioid Receptor Antagonist, Methocinnamox (MCAM)
2020
·
Hudson R. Smith
, Joshua C. Zamora
, et al.
·
The FASEB Journal
·
1
Probing chemical space and conformational changes for subtype-selective orexin receptor antagonists
2026
·
Hudson R. Smith
, Elizabeth Saab
, et al.
·
RSC Medicinal Chemistry
Long-term Kappa Opioid Receptor Inhibition by Norbinaltorphimine and 14-3-3γ
2024
·
Michael J. Wedemeyer
, Elaine Jennings
, et al.
·
Journal of Pharmacology and Experimental Therapeutics
Discovery of agonists for orphan GPR52 using a ligand-based pharmacophore model and virtual screening
2024
·
Hudson R. Smith
, Ryan M. Murphy
, et al.
·
Journal of Pharmacology and Experimental Therapeutics
Comparing the Neuroprotective Efficacy of P7C3‐A20 to Novel P7C3 Derivatives in a Rodent Model of Paclitaxel‐Induced Peripheral Neuropathy
2019
·
Hudson R. Smith
, Peter M. LoCoco
, et al.
·
The FASEB Journal
Author response: Pharmacological augmentation of nicotinamide phosphoribosyltransferase (NAMPT) protects against paclitaxel-induced peripheral neuropathy
2017
·
Peter M LoCoco
, April L Risinger
, et al.
·
eLife
Show more works
View as search
Works count:
14
Citation count:
114
H-index:
6
I10-index:
3
Year
Topic
Type